Fundraising FoxTrojan Bio
3 known investors
Find your way into Trojan Bio
Sign up to see every warm intro you have to Trojan Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Trojan Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Trojan Bio develops bispecific antibodies for cancer immunotherapy, using an AI-driven platform that pairs a cancer-targeting module with a viral immunity activation module to mark tumor cells as virally infected and recruit anti-viral immune responses. Its approach is designed to be switchable across different tumor types.
Investors · 3
__Twitter.png)
Frequently asked questions
- What does Trojan Bio do?
- Trojan Bio develops bispecific antibodies for cancer immunotherapy, using an AI-driven platform that pairs a cancer-targeting module with a viral immunity activation module to mark tumor cells as virally infected and recruit anti-viral immune responses. Its approach is designed to be switchable across different tumor types.
- Who are Trojan Bio's investors?
- Trojan Bio's investors include Gaingels, NFX, Peregrine Ventures.